Related Experiment Video
Updated: Mar 13, 2026
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Analysis of Pathological Activities of CCN2/CTGF in Muscle Dystrophy
María José Acuña1, Enrique Brandan2
1Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Abstract:
CCN2 or connective tissue growth factor (CTGF) is a matricellular protein that regulates several cellular processes. In skeletal muscle, CTGF is a key modulator of fibrogenesis, is increased in pathological conditions such as muscular dystrophies, and plays a major role in the pathology outcome. Overexpression of CTGF in skeletal muscle of wild-type mice results in muscle damage, fibrosis, and reduction of strength. In contrast, a decrease in CTGF in dystrophic mice increases strength and reduces damage and fibrosis. Thus, CTGF is a relevant target to study in skeletal muscle pathology and its possible modulation by different treatments or potential new drugs to develop new strategies for the treatment of muscular dystrophies. We summarize the techniques used to detect CTGF in the skeletal muscle of dystrophic mdx mice.
Insights
Connective tissue growth factor (CTGF) drives skeletal muscle fibrosis and damage in muscular dystrophies. Reducing CTGF levels in mice improves muscle strength and reduces pathology, highlighting CTGF as a therapeutic target.
Area of Science:
- Biochemistry
- Cell Biology
- Muscle Physiology
Background:
- Connective tissue growth factor (CTGF) is a key matricellular protein regulating cellular processes.
- In skeletal muscle, CTGF significantly influences fibrogenesis and disease progression.
- Elevated CTGF is observed in pathological conditions like muscular dystrophies.
Purpose of the Study:
- To investigate the role of CTGF in skeletal muscle pathology.
- To evaluate CTGF as a potential therapeutic target for muscular dystrophies.
- To summarize methods for detecting CTGF in dystrophic mouse skeletal muscle.
Main Methods:
- Skeletal muscle analysis in wild-type and dystrophic mdx mice.
- Assessment of muscle damage, fibrosis, and strength.
- Review of techniques for CTGF detection in muscle tissue.
Main Results:
- CTGF overexpression in wild-type mice induces muscle damage, fibrosis, and weakness.
- Decreased CTGF in dystrophic mice enhances muscle strength and reduces fibrosis.
- Specific techniques for CTGF detection in mdx mouse skeletal muscle are outlined.
Conclusions:
- CTGF is a critical factor in skeletal muscle fibrosis and pathology.
- Modulating CTGF offers a promising therapeutic strategy for muscular dystrophies.
- Understanding CTGF detection methods is crucial for research in muscle diseases.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...